Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P J Oliveira

Showing results (1-10 of 35) with videos related to

Pageof 4
Sort By:
The Physician and Sportsmedicine|April 29, 2010
Hypertension update and cardiovascular risk reduction in physically active individuals and athletesLeonardo P J Oliveira, Christine E Lawless
Current Sports Medicine Reports|May 31, 2011
Making prudent recommendations for return-to-play in adult athletes with cardiac conditionsLeonardo P J Oliveira, Christine E Lawless
Archives of Biochemistry and Biophysics|February 10, 2000
Carvedilol inhibits the exogenous NADH dehydrogenase in rat heart mitochondriaP J Oliveira, D J Santos, A J Moreno
Physical Review Letters|November 13, 2007
Purely elastic flow asymmetriesR J Poole, M A Alves, P J Oliveira
Biochemistry. Biokhimiia|February 24, 2006
Doxorubicin-induced thiol-dependent alteration of cardiac mitochondrial permeability transition and respirationP J Oliveira, M S Santos, K B Wallace
Current Medicinal Chemistry|November 18, 2011
Re-wiring the circuit: mitochondria as a pharmacological target in liver diseaseC V Diogo, I Grattagliano, P J Oliveira, et al.
Biochemical Pharmacology|May 2, 2001
Protective effect of carvedilol on chenodeoxycholate induction of the permeability transition poreA P Rolo, P J Oliveira, A J Moreno, et al.
Cardiovascular Toxicology|September 6, 2002
Carvedilol reduces mitochondrial damage induced by hypoxanthine/xanthine oxidase: relevance to hypoxia/reoxygenation injuryP J Oliveira, A P Rolo, C M Palmeira, et al.
Bioscience Reports|August 18, 2001
Chenodeoxycholate is a potent inducer of the permeability transition pore in rat liver mitochondriaA P Rolo, P J Oliveira, A J Moreno, et al.
Cardiovascular Toxicology|October 26, 2005
Dietary vitamin E decreases doxorubicin-induced oxidative stress without preventing mitochondrial dysfunctionJ M Berthiaume, P J Oliveira, M W Fariss, et al.
Pageof 4

Showing results (1-10 of 35) with videos related to

Sort By:
Pageof 4
The Physician and Sportsmedicine|April 29, 2010
Hypertension update and cardiovascular risk reduction in physically active individuals and athletesLeonardo P J Oliveira, Christine E Lawless
Current Sports Medicine Reports|May 31, 2011
Making prudent recommendations for return-to-play in adult athletes with cardiac conditionsLeonardo P J Oliveira, Christine E Lawless
Archives of Biochemistry and Biophysics|February 10, 2000
Carvedilol inhibits the exogenous NADH dehydrogenase in rat heart mitochondriaP J Oliveira, D J Santos, A J Moreno
Physical Review Letters|November 13, 2007
Purely elastic flow asymmetriesR J Poole, M A Alves, P J Oliveira
Biochemistry. Biokhimiia|February 24, 2006
Doxorubicin-induced thiol-dependent alteration of cardiac mitochondrial permeability transition and respirationP J Oliveira, M S Santos, K B Wallace
Current Medicinal Chemistry|November 18, 2011
Re-wiring the circuit: mitochondria as a pharmacological target in liver diseaseC V Diogo, I Grattagliano, P J Oliveira, et al.
Biochemical Pharmacology|May 2, 2001
Protective effect of carvedilol on chenodeoxycholate induction of the permeability transition poreA P Rolo, P J Oliveira, A J Moreno, et al.
Cardiovascular Toxicology|September 6, 2002
Carvedilol reduces mitochondrial damage induced by hypoxanthine/xanthine oxidase: relevance to hypoxia/reoxygenation injuryP J Oliveira, A P Rolo, C M Palmeira, et al.
Bioscience Reports|August 18, 2001
Chenodeoxycholate is a potent inducer of the permeability transition pore in rat liver mitochondriaA P Rolo, P J Oliveira, A J Moreno, et al.
Cardiovascular Toxicology|October 26, 2005
Dietary vitamin E decreases doxorubicin-induced oxidative stress without preventing mitochondrial dysfunctionJ M Berthiaume, P J Oliveira, M W Fariss, et al.
Pageof 4